Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Therapy of Nodal Follicular Lymphoma (Grade I/II) Clinical Stage I or II Using Involved Field Radiotherapy in Combination With Rituximab

NCT00509184 is registered in ClinicalTrials.gov with Klaus Herfarth, MD as lead sponsor.

NCT NCT00509184
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00509184 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Therapy of Nodal Follicular Lymphoma (Grade I/II) Clinical Stage I or II Using Involved Field Radiotherapy in Combination With Rituximab
Lead sponsor
Klaus Herfarth, MD
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2008
Completion date
April 30, 2013
Enrollment
85 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

lymphoma, malignant